君实生物(01877)：增持计划时间已过半 熊俊暂未增持公司股份

Core Viewpoint - The chairman of Junshi Biosciences, Mr. Xiong Jun, plans to increase his stake in the company by at least RMB 100 million over the next 12 months, starting from April 12, 2025, with a minimum of RMB 50 million allocated for A-shares [1] Group 1 - Mr. Xiong Jun has not yet executed the share purchase plan due to various factors including reporting periods, equity incentive matters, and funding arrangements [1] - The share purchase plan is still ongoing, and Mr. Xiong intends to proceed with the acquisition of shares during the implementation period [1] - The plan may face risks due to changes in capital market conditions or other unpredictable factors that could hinder the expected outcomes of the share purchase [1]